KRYS Annual CFI
$82.64 M
+$196.72 M+172.44%
31 December 2023
Summary:
As of January 23, 2025, KRYS annual cash flow from investing activities is $82.64 million, with the most recent change of +$196.72 million (+172.44%) on December 31, 2023. During the last 3 years, it has risen by +$93.82 million (+839.09%). KRYS annual CFI is now at all-time high.KRYS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRYS Quarterly CFI
-$34.33 M
-$14.97 M-77.38%
30 September 2024
Summary:
As of January 23, 2025, KRYS quarterly cash flow from investing activities is -$34.33 million, with the most recent change of -$14.97 million (-77.38%) on September 30, 2024. Over the past year, it has dropped by -$139.52 million (-132.63%). KRYS quarterly CFI is now -132.63% below its all-time high of $105.19 million, reached on September 30, 2023.KRYS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRYS TTM CFI
-$89.82 M
-$139.52 M-280.73%
30 September 2024
Summary:
As of January 23, 2025, KRYS TTM cash flow from investing activities is -$89.82 million, with the most recent change of -$139.52 million (-280.73%) on September 30, 2024. Over the past year, it has dropped by -$177.41 million (-202.55%). KRYS TTM CFI is now -202.55% below its all-time high of $87.59 million, reached on September 30, 2023.KRYS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRYS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +172.4% | -132.6% | -202.6% |
| 3 y3 years | +839.1% | -559.1% | +21.3% |
| 5 y5 years | +900.5% | -559.1% | +21.3% |
KRYS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +136.4% | -132.6% | +72.9% | -202.6% | +68.1% |
| 5 y | 5-year | at high | +136.4% | -132.6% | +72.9% | -202.6% | +68.1% |
| alltime | all time | at high | +136.4% | -132.6% | +72.9% | -202.6% | +68.1% |
Krystal Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$34.33 M(+77.4%) | -$89.82 M(-280.7%) |
| June 2024 | - | -$19.35 M(-25.5%) | $49.70 M(-6.4%) |
| Mar 2024 | - | -$25.98 M(+155.7%) | $53.09 M(-35.7%) |
| Dec 2023 | $82.64 M(-172.4%) | -$10.16 M(-109.7%) | $82.64 M(-5.7%) |
| Sept 2023 | - | $105.19 M(-759.2%) | $87.59 M(-370.8%) |
| June 2023 | - | -$15.96 M(-547.9%) | -$32.34 M(-40.8%) |
| Mar 2023 | - | $3.56 M(-168.4%) | -$54.61 M(-52.1%) |
| Dec 2022 | -$114.08 M(-49.7%) | -$5.21 M(-64.7%) | -$114.08 M(-51.5%) |
| Sept 2022 | - | -$14.74 M(-61.4%) | -$235.41 M(-8.7%) |
| June 2022 | - | -$38.22 M(-31.6%) | -$257.84 M(-8.5%) |
| Mar 2022 | - | -$55.91 M(-55.8%) | -$281.93 M(+24.3%) |
| Dec 2021 | -$226.77 M(+1928.2%) | -$126.54 M(+240.5%) | -$226.77 M(+113.0%) |
| Sept 2021 | - | -$37.17 M(-40.4%) | -$106.45 M(+47.9%) |
| June 2021 | - | -$62.32 M(+8242.3%) | -$71.98 M(+577.6%) |
| Mar 2021 | - | -$747.00 K(-88.0%) | -$10.62 M(-5.0%) |
| Dec 2020 | -$11.18 M | -$6.22 M(+130.5%) | -$11.18 M(+101.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$2.70 M(+180.4%) | -$5.55 M(+56.9%) |
| June 2020 | - | -$962.00 K(-26.3%) | -$3.54 M(-7.2%) |
| Mar 2020 | - | -$1.30 M(+120.8%) | -$3.81 M(-23.6%) |
| Dec 2019 | -$4.99 M(-51.7%) | -$591.00 K(-13.3%) | -$4.99 M(-38.9%) |
| Sept 2019 | - | -$682.00 K(-44.8%) | -$8.17 M(-20.2%) |
| June 2019 | - | -$1.24 M(-50.2%) | -$10.24 M(-20.0%) |
| Mar 2019 | - | -$2.48 M(-34.1%) | -$12.80 M(+24.0%) |
| Dec 2018 | -$10.32 M(+4815.7%) | -$3.77 M(+36.7%) | -$10.32 M(+53.7%) |
| Sept 2018 | - | -$2.75 M(-27.5%) | -$6.71 M(+69.1%) |
| June 2018 | - | -$3.80 M(<-9900.0%) | -$3.97 M(+1856.7%) |
| Mar 2018 | - | $0.00(-100.0%) | -$203.00 K(-3.3%) |
| Dec 2017 | -$210.00 K(+1300.0%) | -$159.00 K(+1225.0%) | -$210.00 K(+311.8%) |
| Sept 2017 | - | -$12.00 K(-62.5%) | -$51.00 K(+30.8%) |
| June 2017 | - | -$32.00 K(+357.1%) | -$39.00 K(+457.1%) |
| Mar 2017 | - | -$7000.00 | -$7000.00 |
| Dec 2016 | -$15.00 K | - | - |
FAQ
- What is Krystal Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for Krystal Biotech?
- What is Krystal Biotech annual CFI year-on-year change?
- What is Krystal Biotech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Krystal Biotech?
- What is Krystal Biotech quarterly CFI year-on-year change?
- What is Krystal Biotech TTM cash flow from investing activities?
- What is the all time high TTM CFI for Krystal Biotech?
- What is Krystal Biotech TTM CFI year-on-year change?
What is Krystal Biotech annual cash flow from investing activities?
The current annual CFI of KRYS is $82.64 M
What is the all time high annual CFI for Krystal Biotech?
Krystal Biotech all-time high annual cash flow from investing activities is $82.64 M
What is Krystal Biotech annual CFI year-on-year change?
Over the past year, KRYS annual cash flow from investing activities has changed by +$196.72 M (+172.44%)
What is Krystal Biotech quarterly cash flow from investing activities?
The current quarterly CFI of KRYS is -$34.33 M
What is the all time high quarterly CFI for Krystal Biotech?
Krystal Biotech all-time high quarterly cash flow from investing activities is $105.19 M
What is Krystal Biotech quarterly CFI year-on-year change?
Over the past year, KRYS quarterly cash flow from investing activities has changed by -$139.52 M (-132.63%)
What is Krystal Biotech TTM cash flow from investing activities?
The current TTM CFI of KRYS is -$89.82 M
What is the all time high TTM CFI for Krystal Biotech?
Krystal Biotech all-time high TTM cash flow from investing activities is $87.59 M
What is Krystal Biotech TTM CFI year-on-year change?
Over the past year, KRYS TTM cash flow from investing activities has changed by -$177.41 M (-202.55%)